1Barnes DJ,Melo JV.Primitive,quiescent and difficult to kill:the role of non-proliferating stem cells in chronic myeloid leukemia.Cell Cycle,2006,5:2862-2866.
2Domen J,Weissman IL.Self-renewal,differentiation or death:regulation and manipulation of hematopoietic stem cell fate.Mol Med Today,1999,5:201-218.
3Weissman IL.Stem cells:units of development,units of regeneration,and units in evolution.Cell,2000,100:157-168.
4Weissman IL.Translating stem and progenitor cell biology to the clinic:barriers and opportunities.Science,2000,287:1442-1446.
5Krause DS,Lazarides K,von Andrian UH,et al.Requirement for CS44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.Nat Med,2006,12:1175-1180.
6Taichman RS,Cooper C,Keller ET,et al.Use of the stromal cellderived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.Cancer Res,2002,62:1832-1837.
7M(o)hle R,Sehittenhelm M,Failenschmid C,et al.Functional responsc of leukeamic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.Br J Haematol,2000,110:563-572.
8Wang JC,Dick JE.Cancer stem cells:lessons from leukemia.Trends Cell Biol,2005,15:494-501.
9Dick JE.Stem cell concepts renew cancer research.Blood,2008,112:4793-4807.
10Misaghian N,Ligresti G,Steelmaul LS,et al.Targetting the leukemic stem cell:the Holy Grail of leukemia therapy.Leukemia,2009,23:25-42.
